Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2025-12-30 @ 8:37 PM
Study NCT ID:
NCT04880395
Status:
COMPLETED
Last Update Posted:
2025-07-30
First Post:
2021-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3
Sponsor:
Fundación Huésped
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-26
First Submit QC Date:
None
Study First Post Date:
2021-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-18
Results First Submit QC Date:
None
Results First Post Date:
2025-07-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-29
Last Update Post Date:
2025-07-30
Last Update Post Date Type:
ACTUAL